|
D-Tek renew its exclusivity distribution agreement for the UK market
ELY, Cambridgeshire, March, 2005 - Cambridge Life Sciences Ltd. today announced the renewal of its exclusivity agreement for distributing D-Tek products in the United Kingdom.
“The initial distribution agreement was signed in April 2004. After a slow start, the UK market is currently showing interest in the D-Tek's BlueDOT technology. And we are very pleased by D-Tek decision to renew the exclusivity agreement, so we can carry on promoting its innovative products” said Peter Blake CE of Cambridge Life Sciences Ltd. Mr. Blake also added that D-Tek's BlueDOT is a useful test in pre-screening patient samples before sending them away for testing. With its software package Dr Dot, patient records can be stored electronically. This means that test results can be e-mailed between hospitals quickly and safely.
About Cambridge Life Sciences Ltd.:
Cambridge Life Sciences Ltd. is a leading manufacturer and supplier of diagnostics primarily for autoimmune diseases and the clinical chemistry market, designed to meet the needs of today’s healthcare industry. Cambridge Life Sciences technology and services also includes collaborative research, research and development of biosensor technology and a Reference Laboratory that offers access to new, non-routine and infrequently run tests.
About D-Tek:
D-Tek s.a. is a manufacturer of kits for the serological diagnosis of human autoimmune diseases. With extensive knowledge in research and development and many years’ experience in the field of auto-immunity, D-tek has developed an innovative range of ELISA (BlueWELL) and immunodot (BlueDOT) tests for the diagnosis of autoimmune diseases. In parallel to the constant search for new diagnostic parameters, D-Tek offers now the widest range of immunodot tests available on the world market.
For more information about D-Tek s.a., visit the website.
|
